XXII

Stats

Summary

with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.

Market Cap: 5.01 Million

Primary Exchange: NASDAQ

Website: xxiicentury.com

Shares Outstanding: 30.9 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.8997596353681439

Sector: Manufacturing

Industry: Tobacco Manufacturing

Ethical Flags

Longest drawdown: 2998 trading days

From: 2014-03-10 To: 2024-03-07

Lowest Point:

Ex-Date	Payment Date	Record Date	Declared Date	Amount	Flag	Dividend Type	Qualified	Indicated

Ex-Date	Declared Date	Record Date	Payment Date	Ratio	To Factor	For Factor